Autosomal dominant mutations in sarcomere proteins such as the cardiac troponin T (TNNT2) are the main genetic causes of human hypertrophic cardiomyopathy and dilated cardiomyopathy. Allele-specific silencing by RNA interference (ASP-RNAi) holds promise as a therapeutic strategy for downregulating a single mutant allele with minimal suppression of the corresponding wild-type allele. Here, we propose ASP-RNAi as a possible strategy to specifically knockdown mutant alleles coding for R92Q and R173W mutant TNNT2 proteins, identified in hypertrophic and dilated cardiomyopathy, respectively. Different siRNAs were designed and validated by luciferase reporter assay and following analysis in HEK293T cells expressing either the wild-type or mutant TNNT2 alleles. This study is the first exploration of ASP-RNAi on TNNT2-R173W and TNNT2-R92Q mutations in vitro and gives a base for further application of allele silencing as a therapeutic treatment for TNNT2-mutation-associated cardiomyopathies.
BraunwaldE. Cardiomyopathies: an overview.Circ Res2017;121:711–21
2.
MorimotoS. Sarcomeric proteins and inherited cardiomyopathies.Cardiovasc Res2008;77:659–66
3.
DeoRAlbertCM. Epidemiology and genetics of sudden cardiac death.Circulation2012;125:620–37
4.
McKennaWJMaronBJThieneG. Classification, epidemiology, and global burden of cardiomyopathies.Circ Res2017;121:722–30
5.
RichardsonPMcKennaWBristowMMaischBMautnerBO’ConnellJOlsenEThieneGGoodwinJGyarfasIMartinINordetP. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies.Circulation1996;93:841–2
6.
OlivottoId’AmatiGBassoCVan RossumAPattenMEmdinMPintoYTomberliBCamiciPGMichelsM. Defining phenotypes and disease progression in sarcomeric cardiomyopathies: contemporary role of clinical investigations.Cardiovasc Res2015;105:409–23
7.
PerrySV. Troponin T: genetics, properties and function.J Muscle Res Cell Motil1998;19:575–602
8.
RisiCMPepperIBelknapBLandim-VieiraMWhiteHDDrydenKPintoJRChasePBGalkinVE. The structure of the native cardiac thin filament at systolic Ca2+ levels.Proc Natl Acad Sci USA2021;118:e2024288118
9.
BinWJinJ-P. TNNT1, TNNT2, TNNT3: isoform genes, regulation, and structure-function relationships.Gene2016;582:1–13
10.
HershbergerREParksSBKushnerJDLiDLudwigsenSJakobsPNaumanDBurgessDPartainJLittM. Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy.Clin Transl Sci2008;1:21–6
11.
TadrosHJLifeCSGarciaGPirozziEJonesEGDattaSParvatiyarMSChasePBAllenHDKimJJPintoJRLandstromAP. Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes.J Mol Cell Cardiol2020;142:118–25
12.
MorimotoSYanagaFMinakamiROhtsukiI. Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy.Am J Physiol1998;275:C200–7
13.
AlcalaiRSeidmanJGSeidmanCE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.J Cardiovasc Electrophysiol2008;19:104–10
14.
SunNYazawaMLiuJHanLSanchez-FreireVAbilezOJNavarreteEGHuSWangLLeeAPavlovicALinSChenRHajjarRJSnyderMPDolmetschREButteMJAshleyEALongakerMTRobbinsRCWuJC. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.Sci Transl Med2012;4:130–47
15.
HaradaKPotterJD. Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction.J Biol Chem2004;279:14488–95
16.
HershbergerREPintoJRParksSBKushnerJDLiDLudwigsenSCowanJMoralesAParvatiyarMSPotterJD. Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy.Circ Cardiovasc Genet2009;2:306–13
17.
RepettiGGToepferCNSeidmanJGSeidmanCE. Novel therapies for prevention and early treatment of cardiomyopathies.Circ Res2019;124:1536–50
18.
GiorgioELorenzatiMRivetti di Val CervoPBrussinoACernigojMDella SalaEBartoletti StellaAFerreroMCaiazzoMCapellariSCortelliPContiLCattaneoEBuffoABruscoA. Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy.Brain2019;142:1905–20
BarbaroVNastiAADel VecchioCFerrariSMiglioratiARaffaPLaricciaVNespecaPBiasoloMWilloughbyCEPonzinDPalùGParolinCDi IorioE. Correction of mutant p63 in EEC syndrome using siRNA mediated allele-specific silencing restores defective stem cell function.Stem Cells2016;34:1588–600
21.
DrouetVRuizMZalaDFeyeuxMAureganGCambonKTroquierLCarpentierJAubertSMerienneNBourgois-RochaFHassigRReyMDufourNSaudouFPerrierALHantrayePDéglonN. Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells.PLoS ONE2014;9:e99341
22.
OhnishiYTokunagaKKanekoKHohjohH. Assessment of allele-specific gene silencing by RNA interference with mutant and wild-type reporter alleles.J RNAi Gene Silencing2006;2:154–60
23.
SchwarzDSDingHKenningtonLMooreJTSchelterJBurchardJLinsleyPSAroninNXuZZamorePD. Designing siRNA that distinguish between genes that differ by a single nucleotide.PLoS Genet2006;2:e140
24.
de Yñigo-MojadoLMartín-RuízISutherlandJD. Efficient allele-specific targeting of LRRK2 R1441 mutations mediated by RNAi.PLoS ONE2011;6:e21352
25.
SibleyCRWoodMJ. Identification of allele-specific RNAi effectors targeting genetic forms of Parkinson’s disease.PLoS ONE2011;6:e26194
26.
TakahashiMKatagiriTFuruyaHHohjohH. Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva.Gene Ther2012;19:781–5
27.
HuangHQiaoRZhaoDZhangTLiYYiFLaiFHongJDingXYangZZhangLDuQLiangZ. Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs.Nucleic Acids Res2009;37:7560–9
28.
OhnishiYTamuraYYoshidaMTokunagaKHohjohH. Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi.PLoS ONE2008;3:e2248
29.
HohjohH. Allele-specific silencing by RNA interference.Methods Mol Biol2010;623:67–79
30.
LopesLRElliottPM. A straight forward guide to the sarcomeric basis of cardiomyopathies.Heart2014;100:1916–23
31.
MarstonSB. How do mutations in contractile proteins cause the primary familial cardiomyopathies?J Cardiovasc Transl Res2011;4:245–55
32.
HohjohH. Disease-causing allele-specific silencing by RNA interference.Pharmaceuticals2013;6:522–35
33.
JiangJWakimotoHSeidmanJGSeidmanCE. Allele specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy.Science2013;342:111–4
34.
BongianinoRDenegriMMazzantiALodolaFVolleroABoncompagniSFascianoSRizzoGMangioneDBarbaroSDi FonsoANapolitanoCAuricchioAProtasiFPrioriSG. Allele-specific silencing of mutant mRNA rescues ultrastructural and arrhythmic phenotype in mice carriers of the R4496C mutation in the ryanodine receptor gene (RYR2).Circ Res2017;121:525–36
35.
MatsaEDixonJEMedwayCGeorgiouOPatelMJMorganKKempPJStaniforthAMellorIDenningC. Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.Eur Heart J2014;35:1078–87
36.
FengXZhaoPHeYZuoZ. Allele-specific silencing of Alzheimer’s disease genes: the amyloid precursor protein genes with Swedish or London mutations.Gene2006;371:68–74
37.
XiaXZhouHHuangYXuZ. Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo.Neurobiol Dis2006;23:578–86
38.
MillerVMGouvionCMDavidsonBLPaulsonHL. Targeting Alzheimer’s disease genes with RNA interference: an efficient strategy for silencing mutant alleles.Nucleic Acids Res2004;32:661–8
39.
AmeresSLMartinezJSchroederR. Molecular basis for target RNA recognition and cleavage by human RISC.Cell2007;130:101–12
40.
WaltonSPWuMGredellJAChanC. Designing highly active siRNAs for therapeutic applications.FEBS J2010;277:4806–13
41.
DuQThonbergHWangJWahlestedtCLiangZ. A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites.Nucleic Acids Res2005;33:1671–7
42.
ChiuYLRanaTM. siRNA function in RNAi: a chemical modification analysis.RNA2003;9:1034–48
43.
LaiEC. Micro RNAs are complementary to 3’UTR sequence motifs that mediate negative post-transcriptional regulation.Nat Genet2002;30:363–4
44.
ChipmanLBPasquinelliAE. miRNA targeting: growing beyond the seed.Trends Genet2019;35:215–22
45.
HumphreysDTWestmanBJMartinDIPreissT. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function.Proc Natl Acad Sci USA2005;102:16961–6
46.
BartelDP. MicroRNAs: target recognition and regulatory functions.Cell2009;136:215–33
47.
NoguchiSOgawaMKawaharaGMalicdanMCNishinoI. Allele-specific gene silencing of mutant mRNA restores cellular function in Ullrich congenital muscular dystrophy fibroblasts.Mol Ther Nucleic Acids2014;3:e171
48.
DweckDSanchez-GonzalezMAChangANDulceRABadgerCDKoutnikAPRuizELGriffinBLiangJKabbajMFinchamFDHareJMOvertonJMPintoJR. Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy.J Biol Chem2014;289:23097–111
49.
MartinsASParvatiyarMSFengHZBosJMGonzalez-MartinezDVukmirovicMTurnaRSSanchez-GonzalezMABadgerCDZorioDARSinghRKWangYJinJPAckermanMJPintoJR. In vivo analysis of troponin C knock-in (A8V) mice: evidence that TNNC1 is a hypertrophic cardiomyopathy susceptibility gene.Circ Cardiovasc Genet2015;8:653–64
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
